• Ribociclib Succinate: From Solubility Science to CDK4/6 Assa

  2026-07-01

  Explore how Ribociclib succinate, a leading CDK inhibitor, bridges advanced solubility science with functional assay design for cancer research. Uncover actionable insights on optimizing cell cycle regulation studies and differentiating your workflows.

• CasKAS Maps CRISPR Off-Targets via Single-Stranded DNA Profi

  2026-07-01

  The CasKAS method enables rapid, genome-wide mapping of dCas9 and Cas9 binding specificity by detecting single-stranded DNA generated upon CRISPR binding. This innovation overcomes limitations in speed, cost, and applicability of previous assays, providing a practical tool for dissecting off-target effects in genome engineering.

• Amphotericin B: Applied Protocols for Fungal Infection Resea

  2026-06-30

  Amphotericin B remains the gold standard polyene antifungal antibiotic for modeling fungal infections and membrane-targeting assays. This guide translates the latest synergy findings and membrane interaction insights into actionable workflows, troubleshooting, and advanced research applications for scientists using APExBIO’s validated Amphotericin B.

• GSH and GSSG Assay Kit: Redefining Redox Analysis in Tumor I

  2026-06-30

  Explore how the GSH and GSSG Assay Kit enables high-precision reduced glutathione detection and advanced redox state analysis in tumor immunometabolism. This article offers a unique, mechanistic lens on metabolic adaptations in hypoxic environments, setting it apart from standard approaches.

• ARCA Cy5 EGFP mRNA (5-moUTP): Illuminating Next-Gen mRNA Del

  2026-06-29

  Discover how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables high-precision localization and immune-evasive analysis in advanced mRNA delivery research. This article offers deep assay design insights and unique translational perspectives.

• Doxorubicin Hydrochloride: Mechanisms, Models, and Modern St

  2026-06-29

  This thought-leadership article delves into the mechanistic and translational landscape of Doxorubicin hydrochloride (Adriamycin HCl), offering actionable guidance for researchers navigating cancer chemotherapy and cardiotoxicity. By synthesizing recent findings—including the role of ferroptosis and Nrf2/HO-1 signaling in toxicity mitigation—alongside strategic protocol advice and competitive landscape analysis, this piece empowers translational scientists to redefine their experimental and clinical approaches. With enhanced evidence integration and a forward-looking perspective, the discussion extends beyond standard product pages to equip the community for the next generation of oncology research.

• Homoharringtonine: Cytotoxic Alkaloid Workflows in Cancer &

  2026-06-28

  Homoharringtonine empowers translational research by bridging cancer biology and antiviral discovery with robust protein synthesis inhibition. Its proven efficacy and cross-domain versatility, backed by APExBIO’s high-purity supply, set new standards in both leukemia modeling and SARS-CoV-2 clearance protocols.

• Crizotinib Hydrochloride: ALK Kinase Inhibitor in Assembloid

  2026-06-27

  Crizotinib hydrochloride empowers cancer researchers to dissect oncogenic kinase pathways using physiologically relevant assembloid models that integrate tumor organoids with diverse stromal cell populations. This approach reveals mechanisms of drug resistance and optimizes personalized therapy strategies, transforming preclinical cancer biology research.

• JNK-IN-7: Dissecting JNK Pathway Selectivity in Innate Immun

  2026-06-26

  Explore how JNK-IN-7, a selective JNK inhibitor, enables advanced dissection of apoptosis and innate immune signaling with unprecedented specificity. This article offers a deep dive into mechanistic selectivity and practical assay implications, setting it apart from existing resources.

• Ellagic Acid: Precision CK2 Inhibition for Translational Dis

  2026-06-26

  This article explores the mechanistic and strategic value of Ellagic acid (2,3,7,8-tetrahydroxychromeno chromene dione) as a selective casein kinase 2 (CK2) inhibitor in cancer biology, senescence, and oxidative stress research. Integrating recent advances in AI-driven senolytic discovery and hands-on assay optimization, we provide translational researchers with actionable insights, protocol guidance, and a visionary outlook on the evolving landscape of targeted therapeutics.

• Carbapenemase Gene Dynamics in CREC During the COVID-19 Era

  2026-06-25

  This study systematically characterizes carbapenemase-encoding gene (CEG) prevalence, localization, and transmission in carbapenem-resistant Enterobacter cloacae (CREC) isolates from Guangdong hospitals during the COVID-19 pandemic. Key innovations include high-resolution mapping of blaNDM-1 and other CEGs across plasmids and chromosomes, elucidating efficient horizontal gene transfer and epidemiological patterns critical for resistance surveillance and experimental assay design.

• Mubritinib (TAK 165): Data-Driven Solutions for AML & PEL As

  2026-06-25

  This article delivers evidence-based guidance for optimizing cell viability, proliferation, and cytotoxicity assays using Mubritinib (TAK 165) (SKU B1543). By addressing workflow challenges and integrating quantitative findings, we demonstrate how Mubritinib (TAK 165) from APExBIO provides reliable, selective, and reproducible results in cancer biology and virology research.

• Chlorpromazine Hydrochloride in Advanced Antipsychotic Resea

  2026-06-24

  Chlorpromazine hydrochloride is pivotal for dissecting dopamine receptor pathways and modeling both CNS and liver microenvironments. This article details experimental workflows, cross-system innovations, and troubleshooting strategies empowered by APExBIO’s high-purity reagent.

• Crizotinib Hydrochloride in Patient-Specific Tumor Microenvi

  2026-06-23

  Explore how Crizotinib hydrochloride, a leading ALK kinase inhibitor, advances cancer biology research by enabling precise, context-driven studies of oncogenic signaling within patient-derived tumor microenvironments. This article offers fresh insights and practical guidance for translational scientists.

• Human SAN-Plexus Assembloids Illuminate Neuro-Cardiac Matura

  2026-06-23

  This study presents a human in vitro model integrating PSC-derived sinoatrial node (SAN) and cardiac plexus organoids to investigate neuron-to-pacemaker signaling underlying the maturation of cardiac pacemaker systems. The work enables mechanistic study of neuro-cardiac crosstalk and provides a foundation for modeling human-specific conduction disorders.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page